TC
IHE icon

Trust Company’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Trust Company’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-426
Closed -$22K – 314
2019
Q1 		$22K Sell
426
-210
-33% -$10.4K 0.01% 222
2018
Q4 		$30K Buy
+636
New +$32.6K 0.02% 181

Other funds holding IHE

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Trust Company's IHE Position: Q2 2019 in Review

Trust Company sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2019, closing a stake of 426 shares — an estimated $22K sold.

Trust Company first reported a position in IHE in Q4 2018 and held it in 2 quarters. The position peaked at $30K in Q4 2018. 87 funds tracked by Wall St. Rank hold IHE as of Q2 2019.

  • Trust Company reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2019 after selling out during the quarter.
  • Trust Company sold 426 iShares US Pharmaceuticals ETF shares in Q2 2019, an estimated $22K.
  • Trust Company first reported a position in iShares US Pharmaceuticals ETF in Q4 2018 and held it in 2 quarters.
  • Trust Company's iShares US Pharmaceuticals ETF position peaked at $30K in Q4 2018.
  • 87 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2019.

Based on Trust Company's 13F filing for Q2 2019, filed 8 Jul 2019.